Premium
Losartan therapy for cardiac disease in paediatric M arfan syndrome
Author(s) -
Ewans Lisa J,
Roberts Phillip,
Adès Lesley
Publication year - 2015
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1111/jpc.12823
Subject(s) - medicine , losartan , marfan syndrome , cardiology , disease , blockade , intensive care medicine , pediatrics , angiotensin ii , blood pressure , receptor
A case of severe early‐onset Marfan syndrome (MFS) led us to ask the question: ‘Should an ARB , particularly losartan [intervention], compared with beta blockade alone [comparison], be commenced in all paediatric MFS patients [patient] with aortic root dilatation [outcome]?’ The current literature was critically appraised to address this question.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom